ESR1 and breast carcinoma: Initial studies using the estrogen receptor positive (ER+) breast cancer cell line T47D demonstrated that Activin A could promote Smad-dependent cell cycle arrest (27), whereas more recent evidence suggested that Activin A overexpression could promote epithelial to mesenchymal (EMT) transition, invasion and metastasis of breast cancer (28).